细菌和病毒样本采集市场规模报告| 2031 年全球展望

Publication Month : Feb 2024

  • Report Code : TIPRE00033007
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

【研究报告】细菌和病毒标本采集市场规模预计将从2022年的203.452亿美元增长到2030年的602.003亿美元;预计 2022 年至 2030 年复合年增长率为 14.7%。

分析师观点

细菌和病毒标本采集市场分析解释了市场驱动因素,例如细菌和病毒性疾病患病率的上升,这是影响市场增长的一个独立因素。此外,技术进步预计将在 2022 年至 2030 年期间引入市场新趋势。根据产品类型,市场分为细菌样本采集和病毒样本采集。 2022年,细菌标本采集领域占据更大份额。从应用来看,诊断领域占据最大份额,主导市场。按样本划分,市场分为拭子、细菌传输介质、样本采集套件等。按最终用户细分来看,在预测期内,医院细分市场可能会占据细菌和病毒样本采集市场的相当大份额。

细菌和病毒样本采集是用于细菌和细菌的分离、鉴定和表征。病毒制剂、临床标本的正确收集和运输。在处理潜在感染性临床标本时收集标本并遵守所需的生物安全指南,为医护人员、患者和实验室维持安全的工作环境。

市场洞察

细菌和病毒性疾病的患病率上升

根据ReAct在2022年发布的报告显示,过去细菌感染被低估,造成全球医疗保健负担。例如,经济合作与发展组织(OECD)的报告显示,对第三代头孢菌素耐药的大肠杆菌、肺炎克雷伯菌、耐甲氧西林金黄色葡萄球菌(MRSA)和铜绿假单胞菌等微生物导致医疗保健问题。相关感染(HAI)给医疗保健系统带来了沉重负担。此外,报告进一步显示,63.5%的感染病例是由抗生素耐药菌引起的。   此外,ReAct报告显示,全球有770万人死亡与细菌感染有关,占全球死亡人数的13.6%,即八分之一,使细菌感染成为全球第二大死亡原因。这种不断增加的细菌感染仅由五种细菌引起。其中包括金黄色葡萄球菌、大肠杆菌、肺炎链球菌、肺炎克雷伯菌和铜绿假单胞菌。

美国癌症协会 2023 年报告显示,病毒感染也在增加全球。人乳头瘤病毒 (HPV)、HPV 和宫颈癌、以及 HPV 和其他癌症是病毒感染的主要原因。其中,HPV感染在人群中非常常见。因此,人口中细菌和病毒感染的增加是导致 2020-2030 年预测期内市场增长的一个独立因素。

战略见解< /strong>

未来趋势

微生物标本采集试剂盒的技术进步

培养样本必须由技术人员采集并在实验室进行适当处理。标本采集套件可用于常规培养,每个套件均包含由无菌拭子和运输介质组成的运输系统。为了正确处理和运输收集的标本,公司正在开发创新的标本收集套件。 Fischer Scientific 的“Fisherbrand 细菌培养物采集和运输系统”就是创新样本采集套件的一个例子。该样本采集套件专门用于采集和运输各种细菌、病毒和兼性微生物。

此外,Anaerobe Systems, Inc. 的“BIOME- “保留厌氧微生物组采集套件”是样本采集套件的另一个示例。 BIOME-Preserve 是一种专门的收集套件,可保存活的微生物组样本(例如粪便或粪便样本),用于厌氧和兼性厌氧微生物的生长和分离。此外,样品可以直接冷冻在 BIOME-Preserve 中,以便长期低温保存多种收集物种,如双歧杆菌属、拟杆菌属、布劳特氏菌属、哈利伊真杆菌、阿克曼氏菌和普氏粪杆菌。因此,细菌和病毒标本采集的技术进步可以推动未来细菌和病毒标本采集市场的增长。

报告细分和范围

基于产品类型的见解

基于产品类型、细菌和病毒标本采集市场分为细菌标本采集和病毒标本采集。细菌样本采集领域在 2022 年占据了更大的市场份额。全球范围内不断上升的细菌感染和实验室的常规细菌临床测试是影响 2020-2030 年预测期间该领域增长的独立因素。这是因为环境中存在的细菌会导致农场动物的多种疾病和死亡。为了确定引起感染的特定细菌,细菌培养测试是一种常见的实验室测试,用于帮助诊断某些类型的感染。细菌检测采集的标本有咽喉培养、尿培养、痰培养、血培养、粪便培养等。因此,细菌感染的增加导致对标本采集套件的需求加速,从而导致常规临床检查对影响细分市场的增长负责。

基于应用的见解

根据应用,全球细菌和病毒标本采集市场分为诊断和研究。诊断细分市场在 2022 年占据最大的市场份额,预计 2022 年至 2030 年复合年增长率最高。样本采集套件提供了保护样本并将其运送到实验室进行诊断所需的所有组件。此外,公司正在开发用于诊断临床目的的创新采集套件产品。 Merck 的“Milliflex Rapid System 2.0”就是这样一个例子,旨在使用经过验证的快速微生物学测试方法进行微生物 QC 测试。 “Milliflex Rapid System 2.0”是一种自动化系统,用于污染物微生物的诊断检测,适用于快速无菌、生物负载、过程中和产品放行测试。此外,该产品配备了一系列新功能,并且仍然基于相同的经过验证的 ATP 生物发光技术,为更快的临床结果提供了丰厚的好处。这些包括快速且可重复的结果、易于操作和操作。验证等。

基于最终用户的见解

基于最终用户,全球细菌和病毒样本采集市场分为医院、诊断实验室、学术和实验室。研究机构等。医院部门将占据细菌和病毒标本采集市场的最大份额。患有呼吸道病毒和细菌感染的患者数量不断增加,并为抗菌药物治疗提供了依据,这是医院对标本采集套件需求不断增长的因素。此外,急症护理医院中医疗保健相关感染 (HAI) 病例的激增提高了医院细菌和病毒标本采集产品的利用率,从而主导了 2020-2030 年预测期间的市场增长。

按产品类型划分的兽医诊断市场  2022年和2030年

区域分析

北美细菌和病毒标本采集市场分为美国、加拿大和墨西哥。该地区的市场增长归因于病毒性疾病的增加——这是一个积极影响市场增长的独立因素。根据西奈山伊坎医学院 2023 年的报告,在美国,脑炎通常是由疱疹病毒和虫媒病毒引起的病毒感染引起的。美国国立卫生研究院 (NIH) 的报告显示,在美国,脑炎每年导致约 19,000 例住院治疗、230,000 例住院延误以及 6.5 亿美元的住院费用。因此,随着脑炎病毒感染的增加,对细菌和病毒标本采集套件的需求加速。

此外,企业正在通过细菌和病毒标本采集套件开发创新产品。 Abbott 的“multi-Collect 标本采集套件”就是这样的一个例子。该产品专门采集多个标本,提供实时CT/NG样本。此外,该产品还专门用于收集和运输男性和女性标本,例如拭子和标本。尿液用于检测细菌,包括沙眼衣原体和淋病奈瑟菌。这些显着的发展将加速 2020 年至 2030 年预测期内美国细菌和病毒标本采集的采用。

同样,亚太地区的复合年增长率将最高2020-2030 年预测期内的细菌和病毒标本采集市场。这是由于亚太地区顶尖企业参与了细菌和病毒样本采集套件的开发。 Marken 就是涉及生物样本试剂盒生产和交付的例子之一。 Marken 也是以患者为中心的全球试剂盒服务的端到端解决方案合作伙伴,包括用于项目管理和开发任何规格产品的定制样品采集试剂盒。例如,2020 年 6 月,Marken 宣布利用 Marken 的服务组合生产 COVID-19 检测试剂盒,包括直接面向患者 (DTP) 和家庭医疗保健 (HHC) 服务,使该公司能够通过为患者提供支持来支持正在进行的临床试验远程覆盖全球 80 个国家/地区。因此,亚太地区顶尖竞争者推出的创新产品将促进 2020-2030 年预测期内细菌和病毒标本采集市场的增长。

报告简介全球细菌和病毒标本采集市场的领先企业。其中包括Thermo Fisher Scientific、Quidel Corporation、QIAGEN NV、WuXi Nest Biotechnology Co., Ltd.、DiaSorin SpA、Titan Biotech Ltd、Spectrum Solutions LLC、Becton Dickinson and Company、COPAN Diagnostic Inc.、Longhorn Vaccines and Diagnostic LLC。< /span>

  • 2023 年 1 月,QIAGEN 宣布推出 EZ2 Connect MDx 平台,旨在用于诊断实验室的自动化样本处理。从研究的角度来看,新产品的推出正在为全球提供一个用于自动化样品处理的体外诊断(IVD)平台。此外,EZ2 Connect MDx 使实验室能够在短短 30 分钟内从 24 个样本中纯化 DNA 和 RNA,并且新设备符合欧盟 (EU) CE-IVD 合规性,可在美国、加拿大和其他国家/地区使用。 ;
  • 2021年9月,赛默飞世尔科技宣布推出“SpeciMAX稳定唾液采集套件”,以安全采集唾液用于研究目的。 SpeciMAX 稳定唾液采集试剂盒将病毒核酸保存在无害的稳定溶液中,可灭活常见呼吸道病毒,从而实现更安全的样本采集。
  • 2021 年 8 月,康德乐 (Cardinal Health) 宣布与 Abbott 和 Quidel 建立合作伙伴关系用于快速非处方 (OTC) COVID-19 检测。此外,通过此次合作,康德乐的实验室产品组合现在可以支持针对工作场所、旅行和医疗场所的定制测试和监测计划。酒店业。此外,合作伙伴关系还提供全面的解决方案,包括家庭检测、快速现场检测、PCR(分子检测)以及现场或家庭标本采集。
  • 2020年5月,美国食品和药物管理局 (FDA) 在大流行期间宣布了 Everlywell 的独立家用 COVID-19 测试样本采集套件。该套件专门用于收集样本并将其运送至实验室进行处理。

公司简介

  • Thermo Fisher Scientific
  • Quidel Corporation
  • QIAGEN NV
  • 无锡巢生物科技有限公司.
  • DiaSorin SpA
  • Titan Biotech Ltd
  • Spectrum Solutions LLC
  • Becton迪金森公司
  • COPAN Diagnostic Inc.
  • Longhorn Vaccines and Diagnostic LLC
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  • Thermo Fisher Scientific
  • Quidel Corporation
  • QIAGEN N.V.
  • WuXi Nest Biotechnology Co., Ltd.
  • DiaSorin S.p.A
  • Titan Biotech Ltd
  • Spectrum Solutions LLC
  • Becton Dickinson and Company
  • COPAN Diagnostic Inc.
  • Longhorn Vaccines and Diagnostic LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports